Evidence map›Paper›PMID 35764542›Full record

ArticleZhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology2022

[Expert consensus on measurement and clinical application of serum HBV RNA in patients with chronic HBV infection].

Y N Liu, R Fan, R F Yang, S Liu, J Wang, H Liao, C Qiu, R Deng, H X Huang, P Hu and 7 more

Abstract readConsensus Statement
PubMed Full text at PMC Publisher
In one paragraph

Article in Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Article
  2. [Progress on the research of liver diseases in 2022].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Y N LiuDepartment of Microbiology & Infectious Disease Center, Peking University Health Science Center, Beijing 100191, China.
R FanGuangdong Provincial Institute of Liver Disease, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
R F YangPeking University People's Hospital, Peking University Hepatology Institute, Beijing 100044, China.
S LiuGuangdong Provincial Institute of Liver Disease, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
J WangDepartment of Microbiology & Infectious Disease Center, Peking University Health Science Center, Beijing 100191, China.
H LiaoDepartment of Clinical Laboratory, Shenzhen Third People's Hospital, Southern University of Science and Technology, National Clinical Research Center for Infectious Diseases, Shenzhen 518112, China.
C QiuDepartment of Infectious Diseases, Huashan Hospital Affiliated to Fudan University, Shanghai 200040, China.
R DengGuangdong Provincial Institute of Liver Disease, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
H X HuangDepartment of Microbiology & Infectious Disease Center, Peking University Health Science Center, Beijing 100191, China.
P HuDepartment of Infectious Diseases, the Second Affiliated Hospital of Chongqing Medical University, Institute for Viral Hepatitis of Chongqing Medical University, Chongqing 400010, China.
S J ZhengLiver Diseases Center, Beijing Youan Hospital, Capital Medical University, Beijing 100069, China.
W H ZhangDepartment of Infectious Diseases, Huashan Hospital Affiliated to Fudan University, Shanghai 200040, China.
X M ChenDepartment of Microbiology & Infectious Disease Center, Peking University Health Science Center, Beijing 100191, China.
Hongsong ChenPeking University People's Hospital, Peking University Hepatology Institute, Beijing 100044, China.
Jian SunGuangdong Provincial Institute of Liver Disease, Guangdong Provincial Key Laboratory of Viral Hepatitis Research, Department of Infectious Diseases, Nanfang Hospital, Southern Medical University, Guangzhou 510515, China.
Fengmin LuPeking University People's Hospital, Peking University Hepatology Institute, Beijing 100044, China Department of Microbiology & Infectious Disease Center, Peking University Health Science Center, Beijing 100191, China.
Cooperative Group of Basic Research and Experimental Diagnosis of Liver

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Since the discovery of circulating hepatitis B virus (HBV) RNA in the peripheral blood of patients with chronic hepatitis B in 1996, a growing number of studies have focused on clarifying the biological characteristics and clinical application value of serum HBV RNA. This consensus mainly summarizes the research progress of serum HBV RNA existing profiles, quantitative detection methods, and current clinical applications. In order to better apply this indicator for the clinical management of patients with chronic HBV infection, recommendations on quantitative detection target regions, detection results, and clinical applications are put forward.

Indexed as

Hepatitis B, ChronicHepatitis B virusHumansRNA, ViralRNA, Viral

Identifiers

PMID35764542
PMCPMC12770410

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.